-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Regenerative Medical Technology Group Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2018 to Q1 2024.
- Regenerative Medical Technology Group Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was $108K, a 1494% increase year-over-year.
- Regenerative Medical Technology Group Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$419K, a 62.4% increase from 2022.
- Regenerative Medical Technology Group Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$1.11M, a 88.7% increase from 2021.
- Regenerative Medical Technology Group Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$9.88M, a 2961% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)